1 of 4 The PCI 1 Process & UVBI History

Dr. Dan Fernandez explains how he started his journey to create his proprietary PCI-1 treatment process. He elaborates and Honors the Scientist that Created this treatment method and the Success demonstrated in the US from the 1920s to the 1960s and why this treatment method was shelved.

Our initial goal was to provide treatment for persons that are resistant and or intolerant to retrovirals. As time passes by, more people become increasingly intolerant to retrovirals and today it’s very difficult to keep up with all the mutations. One of PCIs advantages is, Pathogens cannot mount a resistance to our treatment. and it can be utilized to treat both Humans and Animals.

In years past, Dr. Fernandez has refrained from speaking publicly about the results obtained in International Government Approved Controlled Clinical Trials in HIV/AIDS. He believes that in light of the need to provide a cure for COVID-19, it was time for him to share with the world the efficacy of his treatment and how it could be used as a viable method to treat people that have been infected by COVID-19.

Pursuant to many requests from the Scientific community worldwide, he is in the process of publishing the results that he obtained from the HIV government-controlled clinical trials. For more in-depth details and information about our treatment process, please visit our website at; gmtpci.com.

Please subscribe to our channel and feel free to contact us or leave comments below.